NCT05312411 A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05302921 Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors Status COMPLETED Phase PHASE2
NCT05235165 Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma Status RECRUITING Phase PHASE3
NCT05194605 Predictive Models of Treatment Responses and Survival Outcomes in Patients With Osteosarcoma Status UNKNOWN Phase N/A
NCT05182164 Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas Status RECRUITING Phase PHASE2
NCT05101655 Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of Osteosarcoma Status COMPLETED Phase N/A
NCT05093322 A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05057130 Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors Status RECRUITING Phase PHASE2/PHASE3
NCT05024253 Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. Status COMPLETED Phase PHASE3
NCT04995003 HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma Status RECRUITING Phase PHASE1
NCT04897321 B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) Status RECRUITING Phase PHASE1
NCT04886765 A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma Status UNKNOWN Phase PHASE1/PHASE2
NCT04864821 Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor Status UNKNOWN Phase EARLY_PHASE1